Onconic Therapeutics온코닉테라퓨틱스
476060 · KOSDAQ · ₩476060 · 온코닉테라퓨틱스
₩12,110▼ ₩510 (4.04%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | |
|---|---|---|
| Revenue | ₩53B | ₩15B |
| Operating income | ₩13B | −₩4.8B |
| Net income | ₩16B | −₩8.1B |
| Net income to shareholders | ₩16B | −₩8.1B |
Balance sheet
| 2025 | 2024 | |
|---|---|---|
| Total assets | ₩76B | ₩61B |
| Current assets | ₩64B | ₩52B |
| Cash and equivalents | ₩47B | ₩43B |
| Total liabilities | ₩3.7B | ₩4.9B |
| Current liabilities | ₩3.6B | ₩4.8B |
| Borrowings | ₩0 | ₩0 |
| Total equity | ₩72B | ₩56B |
| Shareholders' equity | ₩72B | ₩56B |
Cash flow
| 2025 | 2024 | |
|---|---|---|
| Cash from operations | ₩11B | −₩7.8B |
| Capital spending | ₩303M | ₩141M |
| Free cash flow | ₩11B | −₩8B |
Consolidated where available. Amounts in won.
Also known as: Onconic Therapeutics / 온코닉테라퓨틱스 / 476060 / KRX:476060
Source: KRX statistical information